XCOPRI 250 mg Maintenance Pack - 50 mg (28), 200 mg (28) 56 Count
RxNorm 2283515

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2283515 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: XCOPRI 250 mg Maintenance Pack - 50 mg (28), 200 mg (28) 56 Count.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
XCOPRI 250 mg Maintenance Pack - 50 mg (28), 200 mg (28) 56 Count
AUI:12628527
View
SY
Xcopri 250 mg Maintenance Pack - 50 mg (28), 200 mg (28) 56 Count
AUI:12628528
View
BPCK
{28 (cenobamate 200 mg Oral Tablet [Xcopri]) / 28 (cenobamate 50 mg Oral Tablet [Xcopri]) } Pack [Xcopri 250 mg Maintenance Pack]
AUI:12373128
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSN

Prescribable Name (PSN):
XCOPRI 250 mg Maintenance Pack - 50 mg (28), 200 mg (28) 56 Count
(Atom ID: 12628527)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
XCOPRI 250 MG Maintenance Pack - 50 MG (28), 200 MG (28) 56 Count
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2283515
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12628527
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2283515
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SY

Synonym (SY):
Xcopri 250 mg Maintenance Pack - 50 mg (28), 200 mg (28) 56 Count
(Atom ID: 12628528)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Xcopri 250 MG Maintenance Pack - 50 MG (28), 200 MG (28) 56 Count
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2283515
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12628528
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2283515
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
BPCK

Brand Name Pack (BPCK):
{28 (cenobamate 200 mg Oral Tablet [Xcopri]) / 28 (cenobamate 50 mg Oral Tablet [Xcopri]) } Pack [Xcopri 250 mg Maintenance Pack]
(Atom ID: 12373128)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{28 (cenobamate 200 MG Oral Tablet [Xcopri]) / 28 (cenobamate 50 MG Oral Tablet [Xcopri]) } Pack [Xcopri 250 MG Maintenance Pack]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2283515
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12373128
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
2283515
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
08/27/2024
Date the RxNorm atom became obsolete

Patient Education

Cenobamate


Cenobamate is used alone or with other medications to treat certain types of partial onset seizures (seizures that involve only one part of the brain) in adults. Cenobamate is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]


* Please review the disclaimer below.